The Effect of PGAM5 on Regulating Mitochondrial Dysfunction in Ischemic Stroke

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Ischemic stroke presents high mortality and economic burden, necessitating novel therapeutic targets.
• Exploring the role of phosphoglycerate mutase family member 5 (PGAM5) in ischemic stroke is crucial for developing new treatments.

Purpose of the Study:

• To investigate the impact of PGAM5 on oxidative stress and mitochondrial dysfunction in an in vitro model of ischemic stroke.

Main Methods:

• Established an oxygen-glucose deprivation/reoxygenation (OGD/R) model using SH-SY5Y neuroblastoma cells.
• Assessed cell viability, apoptosis, mitochondrial membrane potential (MMP), reactive oxygen species (ROS), malondialdehyde (MDA), and superoxide dismutase (SOD) levels.
• Analyzed the expression of autophagy markers (LC3-II/I, ATG5) and the PINK1/Parkin signaling pathway.

Main Results:

• PGAM5 overexpression worsened OGD/R-induced cell injury, while PGAM5 inhibition improved cell viability and reduced apoptosis.
• OGD/R impaired mitochondrial function and increased oxidative stress, effects amplified by PGAM5 overexpression and reversed by PGAM5 knockdown.
• PGAM5 modulated the PINK1/Parkin pathway, suggesting a role in mitochondrial quality control.

Conclusions:

• PGAM5 significantly contributes to oxidative stress and mitochondrial dysfunction in ischemic stroke.
• PGAM5 regulates the PINK1/Parkin signaling pathway, highlighting its involvement in cellular damage mechanisms.
• PGAM5 represents a promising therapeutic target for ischemic stroke treatment.